Trial Details

WITHDRAWN
Basic Information
Clinical ID c1460
Identifier NCT03237260
Trial Title An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Vedolizumab
Participant Information
Sponsor University of Pennsylvania
City Philadelphia
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2017-07-01
Primary Completion Date 2019-02-01
Completion Date 2019-02-01